MediGene AG announced the appointment of Peter Llewellyn-Davies as member of the company's executive management board with effect from October 01, 2012. To date Chief Financial Officer of Wilex AG, Munich, the Briton Peter Llewellyn- Davies was responsible for a broad range of functions including accounting, controlling, finance, legal, human resources and investor relations. He was a member of Wilex's Executive Management Board from 2006 until the end of August 2012.

Over the last six years, he has been instrumental in the initial public offering, key strategic transactions and acquisitions as well as their integration, and a range of capital measures. Prior to this, he was Managing Director of MxFCller Dairy (UK) and Executive Finance Director at SxFCd-Chemie AG, where he oversaw the international expansion of the Munich-based company. At Medigene AG, Peter Llewellyn-Davies succeeds Arnd Christ, who is leaving the company at his own request after two-and-a-half successful years as CFO in order to pursue a new professional challenge.